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An observational study
of asymmetry in CMT1A
Charcot-Marie-Tooth (CMT) disease is a
clinically and genetically heterogeneous
group of inherited neuropathies that was
ﬁrst described in 1886. CMT1A is the
commonest form of CMT and accounts
for 70% of demyelinating CMT
(CMT1).
1 It is an autosomal dominant
neuropathy due to a 1.4 Mb duplication
or rarely a triplication on chromosome
17p11.2 that contains the peripheral
myelin protein 22 (PMP22) gene.
Potential pathogenic mechanisms include
alterations in protein homoeostasis, chol-
esterol dysregulation, increased calcium
inﬂux via P2X7 upregulation resulting in
dysmyelination and/or disruption of axon-
glia interactions contributing to axonal
loss.
2 The characteristic phenotype deli-
neated by Harding and Thomas is of
childhood-onset distal wasting, weakness
and sensory loss, which progresses slowly
over decades in a length-dependent, sym-
metrical manner.
3 One study of paediatric
CMT reported asymmetry of foot align-
ment and ankle ﬂexibility in 3–5% of
patients and found that asymmetry was
associated with greater overall neuropathy
severity according to CMTNS scale but
there was no breakdown according to spe-
ciﬁc CMT genotypes.
4 Careful clinical
descriptions from many large CMT1A
cohorts have not reported signiﬁcant
asymmetry in muscle strength or sensory
deﬁcits.
56
However, rare cases of superimposed
inﬂammatory neuropathy or radiculopa-
thy, either secondary to degenerative
spinal disease or as a complication of
enlarged nerve roots, have been reported
in CMT1A. There has been one reported
case of marked asymmetry with unilateral
footdrop without an alternative explan-
ation despite extensive assessment in a
19-year-old male patient.
7 Interestingly,
this patient was one of a pair of monozy-
gotic twins with CMT1A who had similar
electrophysiological markers of the
disease but signiﬁcant differences in
semeiology. In practice, it is important to
know how much asymmetry is allowed in
this condition so as not to assume that
asymmetry always suggests a differential
or coincidental diagnosis. No study to
date has systematically examined this
issue.
We performed a retrospective case
series review in a cohort of patients with
clinically and genetically conﬁrmed
CMT1A followed up at least annually at
the inherited neuropathy clinic in the
National Hospital for Neurology and
Neurosurgery. Routine practice involves
annual clinical assessment using the CMT
Examination Score (CMTES), which
includes Medical Research Council
(MRC) scoring of muscle strength and
validated scales for quantiﬁcation of pin-
prick (PP) and vibration sensation (VS)
deﬁcit .We recorded presence of asym-
metry in strength in the commonly
affected ﬁrst dorsal interosseous (FDIO)
and abductor pollicis brevis (APB) muscles
in the upper limbs (UL) and ankle dorsi-
ﬂexion and plantarﬂexion in the lower
limbs (LL). Asymmetry was deﬁned as a
difference of greater than 1 MRC grade
in contralateral muscles (without differen-
tiation between grade 4−, 4 and 4+) and
asymmetry of sensation as a difference of
1 point on the CMTES PP and vibration
scales. We excluded patients with electro-
physiological evidence of superimposed
compressive neuropathy and those with
examination ﬁndings suggesting signiﬁcant
foot, ankle and hip problems or spinal
deformities, which are commonly asso-
ciated orthopaedic complications in inher-
ited neuropathy that can contribute to
non-neuropathic motor deﬁcits.
One hundred and eighty patients were
included in this review, 40.1% male, mean
(SD) age at examination was 41.7 (14.8)
years. Asymmetry of strength was seen in
38 patients (21.1%), of whom 24 (13.3%)
had asymmetrical UL and 17 (9.4%) asym-
metrical LL strength. The distribution of
asymmetry in UL was as follows: FDIO
(range: 1–2 points on MRC scale) in 13
patients (7.2%) and APB (range: 1–3
points) in 14 patients (7.8%). In the LL:
ankle dorsiﬂexion (range: 1–2 points) in
17 (9.4%) and ankle plantarﬂexion (range:
2–3 points) in two patients (1.1%; table
1). In three patients asymmetry was noted
in both upper and LL; weaker left FDIO
and right ankle dorsiﬂexion in one patient,
weaker right APB and right dorsiﬂexion in
a second, and right FDIO and right ankle
dorsiﬂexion in the third. Patients with
motor asymmetry were older (mean (SD)
=49.2 (12.9) years with asymmetry; 39.35
(14.48) years without asymmetry;
(p<0.005) and had a more severe neur-
opathy (mean (S.D.) CMTES=13.4 (4.7)
with asymmetry, 9.7 (4.5) without asym-
metry; (p=0.000). There was no correl-
ation between weaker side and handedness
(r=0.11, p=0.52). The proportion of
affected relative to probands were similar
in both groups; 32.3% probands in sym-
metrical and 36.8% in asymmetrical
patients (p=0.49).
In terms of sensation, asymmetry was
noted in 23 patients (12.8%); PP asym-
metry (range: 1–3 points on CMTES scale)
in nine patients (5%) and VS (range 2–4)
in 10 (5.6%; table 1). Asymmetry in
sensory deﬁcit was more common in the
LL 20/23 than in the UL (3/23). In patients
with asymmetry, alternative pathologies
were ruled out through careful clinical
review by an experienced consultant neur-
ologist (MMR), and directed electrophysi-
ology and neuroimaging (MRI of the
brain, spinal cord, nerve roots±plexii). All
differences reported were attributed to
CMT1A. The evolution of these signs and
paraclinical evidence suggests this ﬁnding
as compatible with the natural history of
the condition, a phenomenon which has
not been previously reported. It may be
that dynometry and/or routine electro-
physiological examination of all four limbs
may increase sensitivity for subtle asym-
metry in CMT1A but was beyond the
scope of this observational clinical study.
In conclusion, we observed motor and
sensory asymmetry in a signiﬁcant minor-
ity of patients in this well phenotyped
CMT1A cohort. The presence of asym-
metry alone in CMT1A does not necessar-
ily suggest that an alternative explanation
needs to be sought.
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Table 1 Number of patients with motor
and/or sensory asymmetry according to
differences in MRC and CMTES sensory
scoring systems
Difference 1 2 3 4
MRC score
FDIO 10 3 1 0
APB 10 3 0 0
ADF 11 6 0 0
APF 0 1 1 0
CMTES sensory score
P P 5110
V S 0261
ADF, ankle dorsiflexion; APB, abductor pollicis brevis;
APF, ankle plantar flexion; CMTES,
Charcot-Marie-Tooth Examination Score; FDIO, first
dorsal interosseous; MRC, Medical Research Council;
PP, pinprick; VS, vibration sense.
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